Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Benefits and Safety of Systemic Psoriasis Therapy: Swiss Registry on the Treatment of Psoriasis With Biologics and Systemic Therapeutics

NCT01706692 is registered in ClinicalTrials.gov with Swiss Dermatology Network for Targeted Therapies as lead sponsor.

NCT NCT01706692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01706692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Benefits and Safety of Systemic Psoriasis Therapy: Swiss Registry on the Treatment of Psoriasis With Biologics and Systemic Therapeutics
Lead sponsor
Swiss Dermatology Network for Targeted Therapies
Phase
Observational
Overall status
Recruiting
Start date
February 28, 2011
Completion date
March 15, 2032
Enrollment
1,121 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis